Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

NCT00406393

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +21 more
Locations: City of Hope National Medical Center Duarte, California, United States

UCSD Medical Center La Jolla, California, United States

Stanford Hospital and Clinics Stanford, California, United States

University of Florida College of Medicine (Shands) Gainesville, Florida, United States

View all 24 locations

View Trial Details

Completed

Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT

NCT04629430

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +42 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

A Rollover Study to Provide Continued Treatment With Eltrombopag

NCT01957176

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +23 more
Locations: Novartis Investigative Site Leuven, Belgium

Novartis Investigative Site Shanghai, China

Novartis Investigative Site Paris, France

Novartis Investigative Site Athens, Greece

View all 13 locations

View Trial Details

Completed

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

NCT01596257

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

NCT00423514

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +31 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

NCT03393611

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

NCT00739141

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +22 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Unrelated Donor Stem Cell Transplantation

NCT01364363

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Scripps Green Hospital La Jolla, California, United States

View Trial Details

Completed

Nonmyeloablative Allogeneic Transplant

NCT01272817

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
Locations: Scripps Green Hospital La Jolla, California, United States

View Trial Details

Completed

Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients

NCT04676945

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Hanusch Krankenhaus, 3.Medizinische Abteilung Vienna, Austria

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions